from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3512/PE_PGRS56

LFCtreatmentdescriptionclass of inhibitor

0.626

Amikacinug/mL Amikacintranslation

-1.647

Cap5-10ug/mL Capreomycintranslation

-0.366

Rox10-50 ug/mL Roxithromycintranslation

-0.100

SM2-5 ug/mL Streptomycintranslation

0.480

Tet5-10 ug/mL Tetracyclinetranslation

-1.890

Rif0.2-5ug/mL Rifampicintranscription

-1.664

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.489

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.067

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.442

CPZ10-50 ug/mL Chlorpromazinerespiration

0.707

Clofazimine10-13 ug/mL Clofaziminerespiration

0.087

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.381

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.527

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.626

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.115

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.072

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.576

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.059

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.694

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.061

KCN5-20 ug/mL Potassium cyaniderespiration

1.143

NaN30.2-2 mM Sodium aziderespiration

0.427

Nigericin50 uM Nigericinrespiration

-0.708

TRC10-150 ug/mL Triclosanrespiration

-0.368

TRZ10-25 ug/mL Thioridazinerespiration

-1.157

Valinomycin0.5-10 uM Valinomycinrespiration

0.902

ZnSO42 mM ZnSO4respiration

-0.174

menadione6-10 ug/mL Menadionerespiration

0.171

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.080

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.543

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.353

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.580

NRP_1Non-replicating persistence stage 1dosRassociated

-0.144

Amp0.2mg/mL AmpicillincellWall

-0.034

Cephalexin20-100 ug/mL CephalexincellWall

-1.574

Cerulenin0.32-5 ug/mL CerulenincellWall

0.126

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.020

EMB10-20 ug/mL EthambutolcellWall

-0.622

Eta12-40 ug/mL EthionamidecellWall

-0.077

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.818

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.915

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.157

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.182

BZA0.12 mg/mL BenzamidearomaticAmides

0.363

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.909

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.948

H2O24 mM hydrogen peroxideDNAdamaging

-0.840

Levo10 ug/mL LevofloxacinDNAdamaging

0.176

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.610

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.139

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.042

UVUV-irradiationDNAdamaging

-0.706

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.490

Antimycin12.5-50 ug/mL Antimycin A?

-0.320

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.400

PA_110-50 ug/mL Antitubercular compound PA-1?

0.116

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.830

PA8240.2-2 ug/mL PA-824?

0.620

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.341

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.501

Verapamil50 uM Verapamil?

0.854

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.059

methoxatin10-20 ug/mL Methoxatin?